首页> 外文期刊>Clinical and experimental allergy : >Does regular paracetamol ingestion increase the risk of developing asthma?
【24h】

Does regular paracetamol ingestion increase the risk of developing asthma?

机译:经常摄入扑热息痛会增加患哮喘的风险吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Paracetamol has been widely used for the treatment of pain and fever in patients of all ages since its introduction in the mid-1950s. Although it is an extremely well-tolerated drug, there has been an emerging interest in its potential to increase the risk of a number of conditions including asthma. The reason for this line of investigation, initiated in the late 1980s, are manifold and include early evidence, later dismissed, that paracetamol can aggravate asthma in patients with co-existent aspirin and non-steroidal anti-inflammatory sensitivity [1]; an ecological analysis of two major international studies showing that higher paracetamol sales were associated with higher prevalence of both childhood and adult asthma across multiple centres [2]; and evidence for a plausible biological mechanism through paracetamol-induced inhibition of glutathione pathways in respiratory epithelium, resulting in increased airway inflammation [3]. While there is evidence for and against these associations, the debate on whether paracetamol is a cause of asthma, or whether this association is confounded by other factors, remains unresolved.
机译:自从1950年代中期问世以来,扑热息痛已被广泛用于治疗各个年龄段的患者的疼痛和发烧。尽管它是一种耐受性极高的药物,但人们对它增加包括哮喘在内的多种疾病风险的潜力产生了兴趣。这项研究始于1980年代后期,其原因是多方面的,其中包括早期证据,后来被驳回,对乙酰氨基酚可以使阿司匹林和非甾体类抗炎药并存的患者加重哮喘[1];对两项主要国际研究的生态分析表明,扑热息痛的销售量较高与多个中心的儿童哮喘和成人哮喘的患病率较高相关[2];并通过对乙酰氨基酚诱导的呼吸道上皮中谷胱甘肽途径的抑制,导致呼吸道炎症增加,证实了可能的生物学机制[3]。尽管有证据支持和反对这些关联,但关于扑热息痛是否是哮喘的起因或该关联是否被其他因素所混淆的争论仍未解决。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号